Phospholipase D2 acts as an essential adaptor protein in the activation of Syk in antigen-stimulated mast cells

Blood

Volumn 108, Issue 3, 2006, Pages 956-964

  Jun, Ho Lee ^b   Young, Mi Kim ^b   Nam, Wook Kim ^b   Jie, Wan Kim ^b   Her, Erk ^b   Bo, Kyung Kim ^b   Jong, Hyun Kim ^b   Sung, Ho Ryu ^b   Jong, Woo Park ^b   Dong, Wan Seo ^b   Jeung, Whan Han ^b   Beaven, Michael A ^b   Wahn, Soo Choi ^a  

^a Konkuk University   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; PHOSPHOLIPASE D2; PROTEIN KINASE LYN; PROTEIN KINASE SYK; SMALL INTERFERING RNA;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATALYST; CELL ACTIVATION; CELL MEMBRANE; CONTROLLED STUDY; GENE OVEREXPRESSION; IMMUNOPRECIPITATION; IMMUNOSTIMULATION; IN VITRO STUDY; MAST CELL; MICROSCOPY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT;

EID: 33746582710     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-10-009159     Document Type: Article

References (69)

1. Nadler MJ, Matthews SA, Turner H, Kinet JP. Signal transduction by the high-affinity immunoglobulin E receptor FcεRI: coupling form to function. Adv Immunol. 2000;76:325-355.
2. Vonakis RM, Chen H, Haleem-Smith H, Metzger H. The unique domain as the site on Lyn kinase for its constitutive association with the high affinity receptor for IgE. J Biol Chem. 1997;272:24072-24080.
3. Zhang J, Berenstein EH, Evans RL, Siraganian RP. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J Exp Med. 1996;184:71-80.
4. El-Hillal O, Kurosaki T, Yamamura H, Kinet JP, Scharenberg AM. Syk activation by a src kinase-initiated activation loop phosphorylation chain reaction. Proc Natl Acad Sci U S A. 1997;94:1919-1924.
5. Saitoh S, Arudchandran R, Manetz TS, et al. LAT is essential for FcεRI-mediated mast cell activation. Immunity. 2000;12:525-535.
6. Pivniouk VI, Martin TR, Lu-Kuo JM, et al. SLP-76 deficiency impairs signaling via the high-affinity IgE receptor in mast cells. J Clin Invest. 1999;103:1737-1743.
7. Rivera J. Molecular adapters in FcεRI signaling and the allergic response. Curr Opin Immunol. 2002;14:688-693.
8. Siraganian RP, Zhang J, Suzuki K, Sada K. Protein tyrosine kinase Syk in mast cell signaling. Mol Immunol. 2002;38:1229-1233.
9. Futterer K, Wong J, Grucza RA, Chan AC, Waksman G. Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide. J Mol Biol. 1998;281:523-537.
10. Dinh TT, Kennerly DA. Assessment of receptor-dependent activation of phosphatidylcholine hydrolysis by both phospholipase D and phospholipase C. Cell Regul. 1991;2:299-309.
11. Lin P, Gilfillan AM. The role of calcium and protein kinase C in the IgE-dependent activation of phosphatidylcholine-specific phospholipase D in a rat mast (RBL-2H3) cell line. Eur J Biochem. 1992;207:163-168.
12. Nakashima S, Fujimiya H, Miyata H, Nozawa Y. Antigen-induced biphasic diacylglycerol formation in RBL-2H3 cells: the late sustained phase due to phosphatidylcholine hydrolysis is dependent on protein kinase C. Biochem Biophys Res Commun. 1991;177:336-342.
13. Cissel DS, Fraundorfer PF, Beaven MA. Thapsigargin-induced secretion is dependent on activation of a cholera toxin-sensitive and a phosphatidylinositol- 3-kinase-regulated phospholipase D in a mast cell line. J Pharmacol Exp Ther. 1998;285:110-118.
14. Chahdi A, Choi WS, Kim YM, Fraundorfer PF, Beaven MA. Serine/threonine kinases synergistically regulate phospholipase D1 and 2 and secretion in RBL-2H3 mast cells. Mol Immunol. 2002;38:1269-1276.
15. Way G, O'Luanaigh N, Cockcroft S. Activation of exocytosis by cross-linking of the IgE receptor is dependent on ADP-ribosylation factor 1-regulated phospholipase D in RBL-2H3 mast cells: evidence that the mechanism of activation is via regulation of phosphatidylinositol 4,5-bisphosphate synthesis. Biochem J. 2000;346:63-70.
16. Brown FD, Thompson N, Saqid KM, et al. Phospholipase D1 localises to secretory granules and lysosomes and is plasma-membrane translocated on cellular stimulation. Curr Biol. 1998;8:835-838.
17. Choi WS, Kim YM, Combs C, Frohman MA, Beaven MA. Phospholipase D1 and 2 regulate different phases of exocytosis in mast cells. J Immunol. 2002;168:5682-5689.
18. O'Luanaigh N, Pardo R, Fensome A, et al. Continual production of phosphatidic acid by phospholipase D is essential for antigen-stimulated membrane ruffling in cultured mast cells. Mol Biol Cell. 2002;13:3730-3746.
19. Cockcroft S. Signalling roles of mammalian phospholipase D1 and D2. Cell Mol Life Sci. 2001;58:1674-1687.
20. Exton JH. Phospholipase D-structure, regulation and function. Rev Physiol Biochem Pharmacol. 2002;144:1-94.
21. Freyberg Z, Siddhanta A, Shields D. "Slip, sliding away": phospholipase D and the Golgi apparatus. Trends Cell Biol. 2003;13:540-546.
22. McDermott M, Wakelam MJ, Morris AJ. Phospholipase D. Biochem Cell Biol. 2004;82:225-253.
23. Hammond SM, Jenco JM, Nakashima S, et al. Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-α. J Biol Chem. 1997;272:3860-3868.
24. Colley WC, Sung TC, Roll R, et al. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol. 1997;7:191-201.
25. Schmidt M, Voss M, Weernink PA, et al. A role for Rho-kinase in Rho-controlled phospholipase D stimulation by the m3 muscarinic acetylcholine receptor. J Biol Chem. 1999;274:14648-14654.
26. Powner DJ, Wakelam MJ. The regulation of phospholipase D by inositol phospholipids and small GTPases. FEBS Lett. 2002;531:62-64.
27. Kim Y, Han JM, Park JB, et al. Phosphorylation and activation of phospholipase D1 by protein kinase C in vivo: determination of multiple phosphorylation sites. Biochemistry. 1999;38:10344-10351.
28. Park SK, Min DS, Exton JH. Definition of the protein kinase C interaction site of phospholipase D. Biochem Biophys Res Commun. 1998;244:364-367.
29. Zhang Y, Altshuller YM, Hammond SM, Frohman MA. Loss of receptor regulation by a phospholipase D1 mutant unresponsive to protein kinase C. EMBO J. 1999;18:6339-6348.
30. Sung TC, Altshuller YM, Morris AJ, Frohman MA. Molecular analysis of mammalian phospholipase D2. J Biol Chem. 1999;274:494-502.
31. Lopez I, Arnold RS, Lambeth JD. Cloning and initial characterization of a human phospholipase D (hPLD2). ADP-ribosylation factor regulates hPLD2. J Biol Chem. 1998;273:12846-12852.
32. Jang IH, Lee S, Park JB, et al. The direct interaction of phospholipase C-γ1 with phospholipase D2 is important for epidermal growth factor signaling. J Biol Chem. 2003;278:18184-18190.
33. Lee HY, Park JB, Jang IH, et al. Munc-18-1 inhibits phospholipase D activity by direct interaction in an epidermal growth factor-reversible manner. J Biol Chem. 2004;279:16339-16348.
34. Kim JH, Kim JH, Ohba M, Suh PG, Ryu SH. Novel functions of the phospholipase D2-Phox homology domain in protein kinase Cζ activation. Mol Cell Biol. 2005;25:3194-3208.
35. Ahn BH, Kim SY, Kim EH, et al. Transmodulation between phospholipase D and c-Src enhances cell proliferation. Mol Cell Biol. 2003;23:3103-3115.
36. Choi WS, Hiragun T, Lee JH, et al. Activation of RBL-2H3 mast cells is dependent on tyrosine phosphorylation of phospholipase D2 by Fyn and Fgr. Mol Cell Biol. 2004;24:6980-6992.
37. Ali H, Cunha-Melo JR, Saul WF, Beaven MA. The activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen-stimulated RBL-2H3 cells. Evidence for a novel adenosine receptor. J Biol Chem. 1990;265:745-753.
38. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
39. Kim JH, Kim Y, Lee SD, et al. Selective activation of phospholipase D2 by unsaturated fatty acid. FEBS Lett. 1999;454:42-46.
40. Kim JH, Lee S, Kim JH, et al. Phospholipase D2 directly interacts with aldolase via its PH domain. Biochemistry. 2002;41:3414-3421.
41. 2+ and purified isozymes in washed permeabilized cells. J Biol Chem. 1993;268:1749-1756.
42. Peng Z, Beaven MA. An essential role for phospholipase D in the activation of protein kinase C and degranulation in mast cells. J Immunol. 2005;174:5201-5208.
43. Morris AJ, Frohman MA, Engebrecht J. Measurement of phospholipase D activity. Anal Biochem. 1997;252:1-9.
44. Frohman M, Sung T-C, Morris A. Mammalian phospholipase D structure and regulation. Biochim Biophys Acta. 1999;1439:175-186.
45. Kandel ES, Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/ PKB. Exp Cell Res. 1999;253:210-229.
46. Lee C, Kim SR, Chung JK, et al. Inhibition of phospholipase D by amphiphysins. J Biol Chem. 2000;275:18751-18758.
47. Lee S, Park JB, Kim JH, et al. Actin directly interacts with phospholipase D, inhibiting its activity. J Biol Chem. 2001;276:28252-28260.
48. Lee S, Kim J, Lee C, et al. Collapsin response mediator protein-2 inhibits neuronal phospholipase D2 activity by direct interaction. J Biol Chem. 2002;277:6542-6549.
49. Keshvara LM, Isaacson CC, Yankee TM, et al. Syk- and Lyn-dependent phosphorylation of Syk on multiple tyrosines following B cell activation includes a site that negatively regulates signaling. J Immunol. 1998;161:5276-5283.
50. Furlong MT, Mahrenholz AM, Kim KH, et al. Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk. Biochim Biophys Acta. 1997;1355:177-190.
51. Law CL, Chandran KA, Sidorenko SP, Clark EA. Phospholipase C-γ1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol Cell Biol. 1996;16:1305-1315.
52. Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity. 1996;5:591-604.
53. Vines CM, Potter JW, Xu Y, et al. Inhibition of β2 integrin receptor and Syk signaling in monocytes by the Src family kinase Fgr. Immunity. 2001;15:507-519.
54. Hong JJ, Yankee TM, Harrison ML, Geahlen RL. Regulation of signaling in B cells through the phosphorylation of Syk on linker region tyrosines. A mechanism for negative signaling by the Lyn tyrosine kinase. J Biol Chem. 2002;277:31703-31714.
55. Yanagi S, Sada K, Tohyama Y, et al. Translocation, activation and association of protein-tyrosine kinase (p72syk) with phosphatidylinositol 3-kinase are early events during platelet activation. Eur J Biochem. 1994;224:329-333.
56. Sidorenko SP, Law CL, Chandran KA, Clark EA. Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a 120-kDa phosphoprotein. Proc Natl Acad Sci U S A. 1995;92:359-363.
57. Couture C, Deckert M, Williams S, et al. Identification of the site in the Syk protein tyrosine kinase that binds the SH2 domain of Lck. J Biol Chem. 1996;271:24294-24299.
58. Ganju RK, Brubaker SA, Chernock RD, Avraham S, Groopman JE. β-Chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. J Biol Chem. 2000;275:17263-17268.
59. Oda A, Ochs HD, Lasky LA, et al. CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk. Blood. 2001;97:2633-2639.
60. Saci A, Liu WQ, Vidal M, et al. Differential effect of the inhibition of Grb2-SH3 interactions in platelet activation induced by thrombin and by Fc receptor engagement. Biochem J. 2002;363:717-725.
61. Yu WM, Hawley TS, Hawley RG, Qu CK. Role of the docking protein Gab2 in β(1)-integrin signaling pathway-mediated hematopoietic cell adhesion and migration. Blood. 2002;99:2351-2359.
62. Moon KD, Post CB, Durden DL, et al. Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase. J Biol Chem. 2005;280:1543-1551.
63. Yankee TM, Keshvara LM, Sawasdikosol S, Harrison ML, Geahlen RL. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain. J Immunol. 1999;163:5827-5835.
64. Simon M, Vanes L, Geahlen RL, Tybulewicz VL. Distinct roles for the linker region tyrosines of Syk in FcεRI signaling in primary mast cells. J Biol Chem. 2005;280:4510-4517.
65. Sada K, Zhang J, Siraganian RP. Point mutation of a tyrosine in the linker region of Syk results in a gain of function. J Immunol. 2000;164:338-344.
66. Zhang J, Berenstein E, Siraganian RP. Phosphorylation of Tyr342 in the linker region of Syk is critical for FcεRI signaling in mast cells. Mol Cell Biol. 2002;22:8144-8154.
67. Horn J, Lopez I, Miller MW, Gomez-Cambronero J. The uncovering of a novel regulatory mechanism for PLD2: formation of a ternary complex with protein tyrosine phosphatase PTP1B and growth factor receptor-bound protein GRB2. Biochem Biophys Res Commun. 2005;332:58-67.
68. Difulvio M, Lehman N, Lin X, Lopez I, Gomez-Cambronero J. The elucidation of novel SH2 binding sites on PLD2. Oncogene. 2006;25:3032-3040.
69. Stauffer TP, Meyer T. Compartmentalized IgE receptor-mediated signal transduction in living cells. J Cell Biol. 1997;139:1447-1454.